☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ODD
Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis
May 28, 2021
Vico's VO659 Receives EC's Orphan Drug Designation for Spinocerebellar Ataxia
February 10, 2021
AbbVie's Elezanumab (ABT-555) Receives the US FDA's Orphan Drug and Fast Track Designation for Spinal Cord Injury
September 29, 2020
BioLineRx's Motixafortide (BL-8040) Receives EC's ODD to Treat Pancreatic Cancer in Europe
January 15, 2020
Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure
December 17, 2019
Acceleron's ACE-083 Receives FDA's ODD for Charcot Marie Tooth Disease (CMT)
March 6, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.